-
Transportability of Treatment Effect Measures for Binary Outcomes in Population-Adjusted Indirect Comparisons
Mar 27, 2025, 21:39 PM -
Evaluating the Performance of Claude 3.5 Sonnet in Data Extraction Automation for Systematic Literature Reviews (SLRs)
Mar 27, 2025, 21:39 PM -
The Past, Present, and Future of Demand for Bariatric Surgery in Chile: A Subgroup Analysis for no-income (Group A) FONASA Beneficiaries
Mar 27, 2025, 21:39 PM -
Health Inequality Aversion in the United States and Americans' Views on Health Inequality
Mar 27, 2025, 21:39 PM -
AI Tools for Literature Reviews: Are Current Guidelines Meeting the Needs of Researchers?
Mar 27, 2025, 21:39 PM -
Assessment of Reasoning Agents for building Literature Search Strategies
Mar 27, 2025, 21:39 PM -
Advancing Equity in CAR T-Cell Therapy: An Analysis of Health Technology Assessments by Canada's Drug Agency and the National Institute for Health and Care Excellence
Mar 27, 2025, 21:39 PM -
Disparities in Antipsychotic Prescribing Among the US Medicare Population
Mar 27, 2025, 21:39 PM -
The Impact of Hallucinations in Synthetic Health Data on Prognostic Machine Learning Models
Mar 27, 2025, 21:39 PM -
Development and Prospective Evaluation of the Bladder Utility Symptom Scale (Utility): A Novel Tool to Measure Utilities and Quality of LIfe in Bladder Cancer Patients
Mar 27, 2025, 21:39 PM -
Leveraging Real-World Data and NLP to Identify At Risk Metabolic Dysfunction Associated Steatohepatitis in the General Population
Mar 27, 2025, 21:39 PM -
The Landscape of Current Policy and Health Authority Positions on Intermediate Endpoints (IEs) for Clinical Outcomes in Oncology
Mar 27, 2025, 21:39 PM -
Boosting Predictive Power: Thoughtfully Unleashing the Potential of Machine Learning In Real-World Healthcare Outcome Estimation
Mar 27, 2025, 21:39 PM -
Evaluating Fairness Across Machine Learning Algorithms in Health Models Incorporating Race/Ethnicity as Predictors
Mar 27, 2025, 21:39 PM -
Patient Reported Adverse Psychosocial Outcomes and Identification of Predictive Factors in Those with Lymphoma or Chronic Lymphocytic Leukemia - An analysis of the Lymphoma Coalition's 2024 Global Patient Survey
Mar 27, 2025, 21:39 PM -
Changes in Patient Reported Outcomes Relative to the Time of Disease Progression in Non-Small Cell Lung Cancer
Mar 27, 2025, 21:39 PM -
Payment Models for Sickle-Cell Disease Gene Therapies in Colorado Medicaid: Real-World Data Analysis
Mar 27, 2025, 21:39 PM -
The Clinical and Financial Benefit of Adopting Negative Pressure Therapy to Reduce Surgical Site Complications after Cesarean Section
Mar 27, 2025, 21:39 PM -
How to Use Real-world Data Across Regions to Gain Regulatory Approval: A Case Study
Mar 27, 2025, 21:39 PM -
Accelerated Access Pathways at Canada’s Drug Agency: Evaluating Progress and Future Directions in HTA
Mar 27, 2025, 21:39 PM